CARECLOUD INC - CCLD 8 3/4 PERP (CCLDP) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:CCLDP • US14167R2094

19.43 USD
-0.92 (-4.52%)
Last: Mar 12, 2025, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Overall CCLDP gets a fundamental rating of 4 out of 10. We evaluated CCLDP against 35 industry peers in the Health Care Technology industry. CCLDP scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CCLDP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • CCLDP had positive earnings in the past year.
  • In the past year CCLDP had a positive cash flow from operations.
  • In the past 5 years CCLDP always reported negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: CCLDP reported negative operating cash flow in multiple years.
CCLDP Yearly Net Income VS EBIT VS OCF VS FCFCCLDP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M -40M -60M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -71.82%, CCLDP is doing worse than 72.97% of the companies in the same industry.
  • CCLDP has a worse Return On Equity (-109.17%) than 64.86% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 8.44%, CCLDP belongs to the top of the industry, outperforming 91.89% of the companies in the same industry.
Industry RankSector Rank
ROA -71.82%
ROE -109.17%
ROIC 8.44%
ROA(3y)-32.68%
ROA(5y)-25.49%
ROE(3y)-58.54%
ROE(5y)-43.02%
ROIC(3y)N/A
ROIC(5y)N/A
CCLDP Yearly ROA, ROE, ROICCCLDP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

  • CCLDP has a better Operating Margin (4.69%) than 81.08% of its industry peers.
  • The Gross Margin of CCLDP (43.42%) is worse than 64.86% of its industry peers.
  • In the last couple of years the Gross Margin of CCLDP has remained more or less at the same level.
Industry RankSector Rank
OM 4.69%
PM (TTM) N/A
GM 43.42%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y0.66%
CCLDP Yearly Profit, Operating, Gross MarginsCCLDP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CCLDP is destroying value.
  • CCLDP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CCLDP Yearly Shares OutstandingCCLDP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
CCLDP Yearly Total Debt VS Total AssetsCCLDP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M

2.2 Solvency

  • CCLDP has an Altman-Z score of 20.84. This indicates that CCLDP is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 20.84, CCLDP belongs to the top of the industry, outperforming 89.19% of the companies in the same industry.
  • The Debt to FCF ratio of CCLDP is 0.05, which is an excellent value as it means it would take CCLDP, only 0.05 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 0.05, CCLDP belongs to the best of the industry, outperforming 86.49% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that CCLDP is not too dependend on debt financing.
  • CCLDP has a better Debt to Equity ratio (0.00) than 67.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Altman-Z 20.84
ROIC/WACC0.77
WACC10.9%
CCLDP Yearly LT Debt VS Equity VS FCFCCLDP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 1.03 indicates that CCLDP should not have too much problems paying its short term obligations.
  • CCLDP has a Current ratio of 1.03. This is in the lower half of the industry: CCLDP underperforms 64.86% of its industry peers.
  • A Quick Ratio of 1.01 indicates that CCLDP should not have too much problems paying its short term obligations.
  • CCLDP has a Quick ratio of 1.01. This is in the lower half of the industry: CCLDP underperforms 64.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 1.01
CCLDP Yearly Current Assets VS Current LiabilitesCCLDP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • CCLDP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 102.11%, which is quite impressive.
EPS 1Y (TTM)102.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%165.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.62%

3.2 Future

  • The Earnings Per Share is expected to decrease by -205.12% on average over the next years. This is quite bad
  • The Revenue is expected to grow by 2.47% on average over the next years.
EPS Next Y-800.4%
EPS Next 2Y-205.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.47%
Revenue Next 2Y2.47%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

CCLDP Yearly Revenue VS EstimatesCCLDP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2030 100M 200M 300M
CCLDP Yearly EPS VS EstimatesCCLDP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 647.67 indicates a quite expensive valuation of CCLDP.
  • Based on the Price/Earnings ratio, CCLDP is valued a bit cheaper than the industry average as 67.57% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 28.18, CCLDP is valued quite expensively.
  • CCLDP is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 647.67
Fwd PE N/A
CCLDP Price Earnings VS Forward Price EarningsCCLDP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CCLDP is valued a bit cheaper than the industry average as 70.27% of the companies are valued more expensively.
  • 62.16% of the companies in the same industry are more expensive than CCLDP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 70.18
EV/EBITDA 39.87
CCLDP Per share dataCCLDP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

  • CCLDP's earnings are expected to decrease with -205.12% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-205.12%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • CCLDP has a Yearly Dividend Yield of 3.54%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.60, CCLDP pays a better dividend. On top of this CCLDP pays more dividend than 94.59% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.80, CCLDP pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.54%

5.2 History

  • On average, the dividend of CCLDP grows each year by 21.20%, which is quite nice.
  • CCLDP has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CCLDP has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)21.2%
Div Incr Years0
Div Non Decr Years8
CCLDP Yearly Dividends per shareCCLDP Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

  • The earnings of CCLDP are negative and hence is the payout ratio. CCLDP will probably not be able to sustain this dividend level.
DP-5.14%
EPS Next 2Y-205.12%
EPS Next 3YN/A
CCLDP Yearly Income VS Free CF VS DividendCCLDP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 -20M -40M -60M

More info and screens

Find the best dividend stocksShow peers with best dividend

CARECLOUD INC - CCLD 8 3/4 PERP

NASDAQ:CCLDP (3/12/2025, 8:00:02 PM)

19.43

-0.92 (-4.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)03-13
Earnings (Next)05-12
Inst Owners11.24%
Inst Owner ChangeN/A
Ins Owners37.42%
Ins Owner ChangeN/A
Market Cap822.28M
Revenue(TTM)N/A
Net Income(TTM)-50.77M
Analysts82
Price Target31.59 (62.58%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.54%
Yearly Dividend0.92
Dividend Growth(5Y)21.2%
DP-5.14%
Div Incr Years0
Div Non Decr Years8
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-143.02%
Min EPS beat(2)-357.52%
Max EPS beat(2)71.48%
EPS beat(4)2
Avg EPS beat(4)-48.69%
Min EPS beat(4)-357.52%
Max EPS beat(4)93.25%
EPS beat(8)4
Avg EPS beat(8)-29.99%
EPS beat(12)8
Avg EPS beat(12)-3.98%
EPS beat(16)12
Avg EPS beat(16)0.19%
Revenue beat(2)0
Avg Revenue beat(2)-1.94%
Min Revenue beat(2)-1.99%
Max Revenue beat(2)-1.89%
Revenue beat(4)0
Avg Revenue beat(4)-3.98%
Min Revenue beat(4)-9.77%
Max Revenue beat(4)-1.89%
Revenue beat(8)0
Avg Revenue beat(8)-4.8%
Revenue beat(12)1
Avg Revenue beat(12)-3.54%
Revenue beat(16)3
Avg Revenue beat(16)-2.31%
PT rev (1m)-1.92%
PT rev (3m)20.57%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.2%
EPS NY rev (1m)0%
EPS NY rev (3m)8.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE 647.67
Fwd PE N/A
P/S 7.41
P/FCF 70.18
P/OCF 42.93
P/B 17.68
P/tB 113.95
EV/EBITDA 39.87
EPS(TTM)0.03
EY0.15%
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)0.28
FCFY1.42%
OCF(TTM)0.45
OCFY2.33%
SpS2.62
BVpS1.1
TBVpS0.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -71.82%
ROE -109.17%
ROCE 10.69%
ROIC 8.44%
ROICexc 8.95%
ROICexgc 61.55%
OM 4.69%
PM (TTM) N/A
GM 43.42%
FCFM 10.55%
ROA(3y)-32.68%
ROA(5y)-25.49%
ROE(3y)-58.54%
ROE(5y)-43.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1%
GM growth 5Y0.66%
F-Score6
Asset Turnover1.57
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Debt/EBITDA 0
Cap/Depr 48.43%
Cap/Sales 6.7%
Interest Coverage 5.55
Cash Conversion 93.12%
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 1.01
Altman-Z 20.84
F-Score6
WACC10.9%
ROIC/WACC0.77
Cap/Depr(3y)85.6%
Cap/Depr(5y)83.34%
Cap/Sales(3y)8.65%
Cap/Sales(5y)7.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)102.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%165.71%
EPS Next Y-800.4%
EPS Next 2Y-205.12%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-0.62%
Revenue Next Year1.47%
Revenue Next 2Y2.47%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y349.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year612.5%
EBIT Next 3Y103.46%
EBIT Next 5YN/A
FCF growth 1Y33%
FCF growth 3YN/A
FCF growth 5Y-7.81%
OCF growth 1Y-9.74%
OCF growth 3YN/A
OCF growth 5Y17.82%

CARECLOUD INC - CCLD 8 3/4 PERP / CCLDP FAQ

What is the ChartMill fundamental rating of CARECLOUD INC - CCLD 8 3/4 PERP (CCLDP) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CCLDP.


What is the valuation status for CCLDP stock?

ChartMill assigns a valuation rating of 2 / 10 to CARECLOUD INC - CCLD 8 3/4 PERP (CCLDP). This can be considered as Overvalued.


Can you provide the profitability details for CARECLOUD INC - CCLD 8 3/4 PERP?

CARECLOUD INC - CCLD 8 3/4 PERP (CCLDP) has a profitability rating of 3 / 10.


What are the PE and PB ratios of CARECLOUD INC - CCLD 8 3/4 PERP (CCLDP) stock?

The Price/Earnings (PE) ratio for CARECLOUD INC - CCLD 8 3/4 PERP (CCLDP) is 647.67 and the Price/Book (PB) ratio is 17.68.


What is the earnings growth outlook for CARECLOUD INC - CCLD 8 3/4 PERP?

The Earnings per Share (EPS) of CARECLOUD INC - CCLD 8 3/4 PERP (CCLDP) is expected to decline by -800.4% in the next year.